Markets

DENTSPLY (XRAY) Beat on Q1 Earnings; Revenues lag - Tale of the Tape

DENTSPLY International Inc ( XRAY ) is one of the leading worldwide manufacturers' dental consumables, dental laboratory products, dental specialty products and consumable medical device products. The company has global operations with sales in more than 120 countries.

Currently, this York, PA- based company carries a Zacks Rank #4 (Sell) but that could change following its first-quarter and full-year 2015 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:

Earnings : The Zacks Consensus Estimate remained steady at 58 cents per share over the last 7 days. DENTSPLY's adjusted EPS of 59 cents beat this estimate and remain unchanged on a year-over-year basis.

Revenues : DENTSPLY's net sales declined 10.1% year over year to $656.3 million, also missing the Zacks Consensus Estimate of $693 million.

Key Stats : Operating margin - excluding one-time items - expanded 100 bps on a year-over-year basis to 18.7%.

Major Factors: Given the recent strength in the US market, and a slight recovery of the Euro, DENTSPLY continue to expect full-year adjusted earnings per share in the range of $2.50 to $2.60.

Stock Price: Following the earnings release, share prices did not show any movement in the pre-market trading session.

Check back later for our full write up on this DENTSPLY earnings report later!

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

DENTSPLY INTL (XRAY): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

XRAY

Other Topics

Earnings Investing Stocks